Related Experiment Videos

Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy

T L Whiteside¹, L M Jost, R B Herberman

¹Pittsburgh Cancer Institute, PA 15213.

Critical Reviews in Oncology/Hematology

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The modified Dunn procedure for slipped capital femoral epiphysis: the Bernese experience.

Journal of children's orthopaedics·2017

Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.

Oncology·2000

[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].

Schweizerische medizinische Wochenschrift·2000

A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission.

British journal of haematology·1999

Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·1998

See all related articles